pI: 8.1903 |
Length (AA): 602 |
MW (Da): 66675 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 2 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
58 | 599 | 1dj3 (A) | 13 | 441 | 27.00 | 0 | 1 | 0.851132 | 1.11 |
65 | 598 | 5i34 (A) | 8 | 428 | 32.00 | 0 | 1 | 0.828743 | 1.09 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_127011)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G57610 | adenylosuccinate synthetase |
Babesia bovis | BBOV_II004950 | adenylosuccinate synthetase, putative |
Brugia malayi | Bm1_50695 | adss-prov protein |
Candida albicans | CaO19.12290 | Adenylosuccinate synthetase |
Candida albicans | CaO19.4827 | Adenylosuccinate synthetase |
Caenorhabditis elegans | CELE_C37H5.6 | Protein C37H5.6, isoform B |
Dictyostelium discoideum | DDB_G0285429 | adenylosuccinate synthetase |
Drosophila melanogaster | Dmel_CG17273 | Adenylosuccinate Synthetase |
Escherichia coli | b4177 | adenylosuccinate synthetase |
Echinococcus granulosus | EgrG_001056900 | adenylosuccinate synthetase |
Echinococcus multilocularis | EmuJ_001056900 | adenylosuccinate synthetase |
Homo sapiens | ENSG00000035687 | adenylosuccinate synthase |
Homo sapiens | ENSG00000185100 | adenylosuccinate synthase like 1 |
Leishmania braziliensis | LbrM.13.0970 | adenylosuccinate synthetase, putative |
Leishmania donovani | LdBPK_131090.1 | adenylosuccinate synthetase, putative |
Leishmania infantum | LinJ.13.1090 | adenylosuccinate synthetase, putative |
Leishmania major | LmjF.13.1190 | adenylosuccinate synthetase, putative |
Leishmania mexicana | LmxM.13.1190 | adenylosuccinate synthetase, putative |
Loa Loa (eye worm) | LOAG_01402 | adss-prov protein |
Mycobacterium leprae | ML0280c | Probable adenylosuccinate synthase PurA (IMP--aspartate ligase) (AdSS) (AMPSase) |
Mus musculus | ENSMUSG00000011148 | adenylosuccinate synthetase like 1 |
Mus musculus | ENSMUSG00000015961 | adenylosuccinate synthetase, non muscle |
Mycobacterium tuberculosis | Rv0357c | Probable adenylosuccinate synthetase PurA (imp--aspartate ligase) (ADSS) (ampsase) |
Mycobacterium ulcerans | MUL_2834 | adenylosuccinate synthetase |
Neospora caninum | NCLIV_038330 | adenylosuccinate synthetase, putative |
Oryza sativa | 4331792 | Os03g0174500 |
Oryza sativa | 4333815 | Os03g0699300 |
Onchocerca volvulus | OVOC7126 | Adenylosuccinate synthetase homolog |
Plasmodium berghei | PBANKA_1131100 | adenylosuccinate synthetase, putative |
Plasmodium falciparum | PF3D7_1354500 | adenylosuccinate synthetase |
Plasmodium knowlesi | PKNH_1117300 | adenylosuccinate synthetase, putative |
Plasmodium vivax | PVX_114710 | adenylosuccinate synthetase, putative |
Plasmodium yoelii | PY03301 | adenylosuccinate synthetase |
Saccharomyces cerevisiae | YNL220W | adenylosuccinate synthase |
Schistosoma japonicum | Sjp_0015930 | ko:K01939 adenylosuccinate synthase [EC6.3.4.4], putative |
Schistosoma mansoni | Smp_055990 | adenylosuccinate synthetase |
Schmidtea mediterranea | mk4.028749.00 | Adenylosuccinate synthetase |
Schmidtea mediterranea | mk4.033749.02 | Adenylosuccinate synthetase |
Schmidtea mediterranea | mk4.014784.00 | |
Schmidtea mediterranea | mk4.031257.00 | Adenylosuccinate synthetase |
Trypanosoma brucei gambiense | Tbg972.11.4160 | adenylosuccinate synthetase, putative |
Trypanosoma brucei | Tb11.v5.0435 | adenylosuccinate synthetase, putative |
Trypanosoma congolense | TcIL3000.11.3610 | adenylosuccinate synthetase, putative |
Trypanosoma cruzi | TcCLB.509683.80 | adenylosuccinate synthetase, putative |
Trypanosoma cruzi | TcCLB.508731.60 | adenylosuccinate synthetase, putative |
Toxoplasma gondii | TGME49_279450 | adenylosuccinate synthetase, putative |
Theileria parva | TP04_0033 | adenylosuccinate synthase, putative |
Wolbachia endosymbiont of Brugia malayi | Wbm0273 | adenylosuccinate synthetase |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu360 | Mycobacterium tuberculosis | essential | nmpdr |
Tb11.02.1120 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.1120 this record | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.1120 this record | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb11.02.1120 this record | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
b4177 | Escherichia coli | non-essential | goodall |
CELE_C37H5.6 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_C37H5.6 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_279450 | Toxoplasma gondii | Probably non-essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | normal (PATO:0000461) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | normal (PATO:0000461) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | normal cell proliferation (no significant loss or gain of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.6
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | adenylosuccinate synthase | Compounds | References |
Type | Source | Notes |
---|---|---|
soluble recombinant protein | Structural Genomics for Pathogenic Protozoa (SGPP) | Tbru022237; Recombinant protein: full-length; Source: T brucei; adenylosuccinate synthetase, putative ; |
4 literature references were collected for this gene.